Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1U20
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,815
Award facts
- Contract value 100% obligated
- $72,815.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72.8K delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Biktarvy 50-200-25 mg tablets, a prescription antiretroviral medication used in HIV treatment. This non-set-aside contract award, issued on January 12, 2026, represents a firm fixed-price transaction with an ultimate completion date of January 13, 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor that plays a critical role in federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.9M through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, providing flexible procurement capabilities for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1U20?
SPE2DR26F1U20 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1U20 worth?
The government has obligated $72,815 on SPE2DR26F1U20.
Is contract SPE2DR26F1U20 an order under another contract?
Yes. SPE2DR26F1U20 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U20 competed?
The extent of competition for SPE2DR26F1U20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award